Kent Kemmish, of Halcyon Molecular discusses how improved genome sequencing can accelerate longevity research at the 2011 H+ Conference in Hong Kong. Kemmish is a geneticist/molecular biologist working with the bionanotech startup to make Ultra Low Cost Sequencing a reality.
Kemmish in the video below states that the human genome has not yet been sequenced.
0 comments:
Post a Comment